7/16/2014 1:54:05 PM
Cellular Biomedicine Group of California raised $10 million through a private placement led by Hong Kong investment banker Francis Leung. CBMG is a cell therapy company that is developing three products for the China market. For serving as lead investor, Mr. Leung has a three-year option to buy an additional 1 million shares at $8 each. If the stock trades above $12 for 20 consecutive trading days, CBMG has the right to compel the purchase. That may happen soon.
Help employers find you! Check out all the jobs and post your resume.
comments powered by